Document:

EX-4.1

 Exhibit 4.1 

THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF THE DEPOSITORY OR
A NOMINEE OF THE DEPOSITORY, WHICH MAY BE TREATED BY THE COMPANY, THE TRUSTEE AND ANY AGENT THEREOF AS OWNER AND HOLDER OF THIS NOTE FOR ALL PURPOSES, INCLUDING THE PAYMENT OF PRINCIPAL AND INTEREST. 

UNLESS AND UNTIL THIS GLOBAL SECURITY IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN DEFINITIVE REGISTERED FORM IN THE LIMITED CIRCUMSTANCES
REFERRED TO IN THE INDENTURE, THIS GLOBAL SECURITY MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITORY TO A NOMINEE OF THE DEPOSITORY OR BY A NOMINEE OF THE DEPOSITORY TO THE DEPOSITORY OR ANOTHER NOMINEE OF THE DEPOSITORY OR BY THE
DEPOSITORY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITORY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITORY. 
 UNLESS THIS CERTIFICATE IS PRESENTED
BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY (55 WATER STREET, NEW YORK, NEW YORK) TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE & CO.
OR SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITORY TRUST COMPANY AND ANY PAYMENT HEREON IS MADE TO CEDE & CO., ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY A PERSON IS WRONGFUL SINCE THE
REGISTERED OWNER HEREOF, CEDE & CO., HAS AN INTEREST HEREIN. 
  

					
	 No. R-1
  
	  			
	CUSIP No. 91529Y AM8	  	$	350,000,000	  

 UNUM GROUP 

3.00% SENIOR NOTES DUE 2021 
 UNUM
GROUP, a corporation duly organized and existing under the laws of the State of Delaware (the “Company”, which term includes any successor Person under the Indenture hereinafter referred to), for value received, hereby promises to pay to
CEDE & CO., as nominee of The Depository Trust Company, or registered assigns, the principal sum of THREE HUNDRED FIFTY MILLION DOLLARS ($350,000,000) on May 15, 2021 (such date is hereinafter referred to as the “Stated
Maturity”), and to pay interest thereon, from May 9, 2016, or from the most recent Interest Payment Date (as defined below) for which interest has been paid or duly provided for, at the rate of 3.00% per annum (the “Interest
Rate”). Interest on this Note shall be payable semi-annually in arrears on May 15 and November 15 of each year (each, an “Interest Payment Date”), commencing November 15, 2016, until the principal hereof is paid or made
available for payment. The interest so payable, and punctually paid or duly provided for, on any Interest Payment Date will, as provided in the Indenture, be paid to the Person in whose name this Note (or one or more Predecessor Securities) is
registered at the close of business on the Regular Record Date for such interest, which shall be the May 1 and November 1, as the case may be (whether or not a Business Day) immediately preceding such Interest Payment Date; provided,

 
that interest payable at the Stated Maturity or on a Redemption Date will be paid to the Person to whom principal is payable on such date. Any such interest not so punctually paid or duly
provided for will forthwith cease to be payable to the Holder on such Regular Record Date and may either be paid to the Person in whose name this Note (or one or more Predecessor Securities) is registered at the close of business on a Special Record
Date for the payment of such Defaulted Interest to be fixed by the Trustee, notice of which shall be given to Holders of Securities of this series not less than 10 days prior to such Special Record Date and shall otherwise be payable, all as more
fully provided in the Indenture. 
 Payments of principal and premium, if any, shall be made upon the surrender of this Note at the
Corporate Trust Office of the Trustee, or at such other office or agency of the Company as may be designated by the Company for such purpose in the Borough of Manhattan, The City of New York or in the City of Chattanooga, Tennessee, in such coin or
currency of the United States of America as at the time of payment shall be legal tender for the payment of public and private debts, by Dollar check drawn on, or transfer to, a Dollar account. Payments of interest on this Note may be made by Dollar
check, drawn on a Dollar account, mailed to the address of the Person entitled thereto as such address shall appear in the Security Register, or, upon written application by the Holder to the Security Registrar setting forth wire instructions not
later than the relevant Regular Record Date, by wire transfer to a Dollar account. The amount of interest payable for any period on any Interest Payment Date shall be computed on the basis of a 360-day year consisting of twelve 30-day months. In the
event that any date on which interest is payable on the Notes is not a Business Day, then payment of interest payable on such date will be made on the next succeeding day which is a Business Day (and without any interest or other payment in respect
of any such delay). 
 Reference is hereby made to the further provisions of this Note set forth on the reverse hereof, which further
provisions shall for all purposes have the same effect as if fully set forth at this place. 
 Unless the certificate of authorization
hereon has been executed by the Trustee referred to on the reverse hereof or an Authentication Agent by the manual signature of one of their respective authorized signatories, this Note shall not be entitled to any benefit under the Indenture or be
valid or obligatory for any purpose. 

  
 -2- 

 IN WITNESS WHEREOF, the Company has caused this Note to be executed and delivered. 

Dated: May 9, 2016 
  

			
	 UNUM GROUP
  

	By:	 	  

		 	Name:
		 	Title:

 CERTIFICATE OF AUTHENTICATION 

This is one of the Securities of the series designated therein referred to in the within-mentioned Indenture. 

Dated: May 9, 2016 
  

			
	THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,
		 	 as Trustee
  

	By:	 	  

		 	Authorized Signatory

  
 -3- 

 This Note is one of a duly authorized issue of securities of the Company designated as its
“3.00% Senior Notes due 2021” (herein sometimes referred to as the “Notes”), initially limited in aggregate principal amount to $350,000,000, issued and to be issued under and pursuant to an Indenture, dated as of August 23,
2012 (the “Indenture”), duly executed and delivered between the Company and The Bank of New York Mellon Trust Company, N.A., as Trustee (the “Trustee”), to which Indenture and all indentures supplemental thereto reference is
hereby made for a statement of the respective rights, limitations of rights, duties and immunities thereunder of the Company, the Trustee and the Holders of the Notes and of the terms upon which the Notes are, and are to be, authenticated and
delivered. 
 The Notes are issuable only in registered form without coupons, in denominations of $2,000 and integral multiples of $1,000 in
excess thereof. As provided in the Indenture and subject to certain limitations therein set forth, Notes so issued are exchangeable for a like aggregate principal amount of Notes of a different authorized denomination, as requested by the Holder
surrendering the same. 
 No sinking fund is provided for the Notes. 

The Notes will be redeemable in whole at any time or in part from time to time prior to April 15, 2021, at the Company’s option, at
a Redemption Price equal to the greater of: 
  

	 	•	 	100% of the principal amount of the Notes to be redeemed, plus accrued and unpaid interest on the principal amount to be redeemed to the Redemption Date; and 

 

	 	•	 	the sum, as calculated by the Independent Investment Banker, of the present values of the remaining scheduled payments of principal and interest on the Notes to be redeemed (exclusive of interest accrued to the
Redemption Date) discounted to the Redemption Date on a semiannual basis (assuming a 360-day year consisting of twelve 30-day months) at the then current Treasury Rate plus 30 basis points, plus accrued and unpaid interest on the principal amount to
be redeemed to the Redemption Date, which is hereinafter referred to as the “Make-Whole Redemption Amount.” 

 On or
after April 15, 2021, the Company will have the right to redeem the Notes, at the Company’s option in whole or in part, at any time and from time to time at a Redemption Price equal to 100% of the principal amount of the Notes to be
redeemed, plus accrued and unpaid interest on the principal amount to be redeemed to the Redemption Date. 
 For the purposes of the
foregoing, the following definitions shall apply: 
 “Comparable Treasury Issue” means the United States Treasury security
selected by the Independent Investment Banker as having a maturity comparable to the remaining term (“Remaining Life”) of the Notes to be redeemed that would be utilized, at the time of selection and in accordance with customary financial
practice, in pricing new issues of corporate debt securities of comparable maturity to the remaining term of such Notes. 
 “Comparable
Treasury Price” means, with respect to any Redemption Date, the average of the Reference Treasury Dealer Quotations for such Redemption Date. 

  
 -4- 

 “Independent Investment Banker” means any of (1) J.P. Morgan Securities LLC and
(2) Barclays Capital Inc., and their respective successors, as selected by the Company, or, if any such firm or the successors, if any, to such firm, as the case may be, are unwilling or unable to serve as such, an independent investment
banking institution of national standing appointed by the Company. 
 “Reference Treasury Dealer” means each of J.P. Morgan
Securities LLC and Barclays Capital Inc., each a primary U.S. Government securities dealer (“Primary Treasury Dealer”), and their respective successors; provided, however, that if any of them ceases to be a Primary Treasury Dealer, the
Company will substitute another Primary Treasury Dealer. 
 “Reference Treasury Dealer Quotations” means, with respect to each
Reference Treasury Dealer and any Redemption Date, the average, as determined by the Independent Investment Banker, of the bid and ask prices for the Comparable Treasury Issue (expressed in each case as a percentage of its principal amount) quoted
in writing to the Independent Investment Banker by such Reference Treasury Dealer at 5:00 p.m., New York City time, on the third Business Day preceding such Redemption Date. 

“Treasury Rate” means, with respect to any Redemption Date, the rate per year equal to: 

(1) the yield, under the heading which represents the average for the immediately preceding week, appearing in the most recently published
statistical release designated “H.15(519)” or any successor publication which is published weekly by the Board of Governors of the Federal Reserve System and which establishes yields on actively traded United States Treasury securities
adjusted to constant maturity under the caption “Treasury Constant Maturities,” for the maturity corresponding to the Comparable Treasury Issue; provided that, if no maturity is within three months before or after the Remaining Life of the
Notes to be redeemed, yields for the two published maturities most closely corresponding to the Comparable Treasury Issue shall be determined and the Treasury Rate shall be interpolated or extrapolated from those yields on a straight line basis,
rounding to the nearest month; or 
 (2) if such release (or any successor release) is not published during the week preceding the
calculation date or does not contain such yields, the rate per year equal to the semiannual equivalent yield to maturity of the Comparable Treasury Issue, calculated using a price for the Comparable Treasury Issue (expressed as a percentage of its
principal amount) equal to the Comparable Treasury Price for such Redemption Date. 
 The Treasury Rate will be calculated on the third
Business Day preceding the Redemption Date. As used in the immediately preceding sentence and in the definition of “Reference Treasury Dealer Quotations” above, the term “Business Day” means any day that is not a Saturday, Sunday
or other day on which commercial banks in New York City are authorized or required by law to remain closed. 
 Notice of any redemption will
be mailed at least 30 but not more than 60 days before the Redemption Date to each Holder of the Notes to be redeemed at its registered address. The notice of redemption for the Notes will state, among other things, the amount of Notes to be
redeemed, the Redemption Date, the manner of calculation of the Redemption Price and the place or places that payment will be made upon presentation and surrender of Notes to be redeemed. If less than all of the Notes are to be redeemed at the
Company’s option, the Trustee will select, in a manner 

  
 -5- 

 
it deems fair and appropriate, the Notes, or portions of the Notes, to be redeemed. Unless the Company defaults in the payment of the Redemption Price, interest will cease to accrue on any Notes
that have been called for redemption at the Redemption Date. 
 The Company will not be required (i) to issue, register the transfer of
or exchange any Notes during a period beginning at the opening of business 15 days before the day of the mailing of a notice of redemption of Notes selected for redemption and ending at the close of business on the day of such mailing, or
(ii) to register the transfer of or exchange any Notes so selected for redemption in whole or in part, except the unredeemed portion of any such Notes being redeemed in part. 

In case an Event of Default shall occur and be continuing, the principal of all of the Notes, together with accrued interest to the date of
declaration, may be declared due and payable in the manner and with the effect provided in the Indenture. 
 The Indenture permits, with
certain exceptions as therein provided, the amendment thereof and the modification of the rights and obligations of the Company and the rights of the Holders of the Securities of each series to be affected under the Indenture at any time by the
Company and the Trustee with the written consent of the Holders of not less than a majority in principal amount of the Securities at the time Outstanding and affected thereby. The Indenture also contains provisions permitting the Holders of
specified percentages in principal amount of the Notes at the time Outstanding, on behalf of the Holders of all the Notes, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and
their consequences. Any such consent or waiver by the Holder of this Note shall be conclusive and binding upon such Holder and upon all future Holders of this Note and of any Note issued in exchange herefor or in lieu hereof whether or not notation
of such consent or waiver is made upon this Note or such other Note. 
 As provided in and subject to the provisions of the Indenture, the
Holder of this Note shall not have the right to institute any proceeding with respect to the Indenture or for the appointment of a receiver or trustee or for any other remedy thereunder, unless (i) such Holder shall have previously given the
Trustee written notice of a continuing Event of Default, (ii) the Holders of not less than 25% in principal amount of the Notes that are Outstanding shall have made a written request to the Trustee to institute proceedings in respect of such
Event of Default as Trustee and offered the Trustee indemnity satisfactory to it, (iii) the Trustee shall not have received from the Holders of a majority in principal amount of the Notes that are Outstanding a direction inconsistent with such
request, and (iv) the Trustee shall have failed to institute any such proceeding for 60 days after receipt of such notice, request and offer of indemnity. The foregoing shall not apply to any suit instituted by any Holder of this Note for the
enforcement of any payment of principal hereof, or any premium of interest hereon on or after the respective due dates expressed herein. 

No reference herein to the Indenture and no provision of this Note or of the Indenture shall alter or impair the obligation of the Company,
which is absolute and unconditional, to pay the principal of, premium, if any, and interest on this Note at the times, places and rate, and in the coin or currency, herein prescribed. 

As provided in the Indenture and subject to certain limitations therein set forth, the transfer of this Note is registrable on the Security
Register upon surrender of this Note for 

  
 -6- 

 
registration of transfer at the Corporate Trust Office of the Trustee or at such other office or agency of the Company as may be designated by it for such purpose in the Borough of Manhattan, The
City of New York or the City of Chattanooga, Tennessee (which shall initially be an office or agency of the Trustee), or at such other offices or agencies as the Company may designate, duly endorsed by, or accompanied by a written instrument of
transfer in form satisfactory to the Security Registrar duly executed by, the Holder thereof or his attorney duly authorized in writing, and thereupon one or more new Notes, of authorized denominations and for the same aggregate principal amount,
will be issued to the designated transferee or transferees by the Security Registrar. No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to recover any tax or
other governmental charge payable in connection therewith. 
 Prior to due presentation of this Note for registration of transfer, the
Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is registered, as the owner thereof for all purposes, whether or not such Note be overdue, and neither the Company, the Trustee nor any
such agent shall be affected by notice to the contrary. 
 No recourse for the payment of the principal (and premium, if any) or interest on
this Note and no recourse under or upon any obligation, covenant or agreement of the Company in the Indenture or any indenture supplemental thereto or in any Note, or because of the creation of any indebtedness represented thereby, shall be had
against any incorporator, stockholder, employee, agent, officer or director or subsidiary, as such, past, present or future, of the Company or of any successor corporation, either directly or through the Company or any successor corporation, whether
by virtue of any constitution, statute or rule of law or by the enforcement of any assessment or penalty or otherwise, all such liability being, by the acceptance hereof and as part of consideration for the issue hereof, expressly waived and
released. 
 THE INDENTURE AND THIS NOTE SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 

All capitalized terms used in this Note which are defined in the Indenture and are not otherwise defined herein shall have the meanings
assigned to them in the Indenture. 

  
 -7- 

 ABBREVIATIONS 

The following abbreviations, when used in the inscription of the face of this Note, shall be construed as though they were written out in full
according to applicable laws or regulations: 
  

					
	TEN COM	  	-	    	as tenants in common
			
	TEN ENT	  	-	    	as tenants by the entireties (Cust)
			
	JT TEN	  	-	    	as joint tenants with right of survivorship and not as tenants in common
			
	UNIF GIFT MIN ACT    	  	-	    	                     Custodian
                    
		  		    	 (Minor)

			
		  		    	under Uniform Gifts to Minors Act                     
		  		    	                                      
                          (State)

 Additional abbreviations may also be used though not in the above list. 

  
 -8- 

 ASSIGNMENT 

FOR VALUE RECEIVED, the undersigned assigns and transfers this Note to: 
  

                          
                                         
                                         
             
  

                          
                                         
                                         
             
  

                          
                                         
                                         
             
 (Insert assignee’s social security or tax
identification number) 
  

                          
                                         
                                         
             
  

                          
                                         
                                         
             
  

                          
                                         
                                         
             
 (Insert address and zip code of assignee) 

and hereby appoints: 
  

                          
                                         
                                         
             
  

                          
                                         
                                         
             
  

                          
                                         
                                         
             
 (Insert transfer agent name and address) 

agent to transfer this Note on the Security Register. The agent may substitute another to act for him or her. 

  
 -9- 

 Dated: 
  

			
	Signed:	 	  

	  
 Signature Guarantee:

 (Sign exactly as your name appears on the other side of this Note) 

Signatures must be guaranteed by an “eligible guarantor institution” meeting the requirements of the Registrar,
which requirements include membership or participation in the Security Transfer Agent Medallion Program (“STAMP”) or such other “signature guarantee program” as may be determined by the Registrar in addition to, or in
substitution for, STAMP, all in accordance with the Securities Exchange Act of 1934, as amended. 

  
 -10-EX-10.1

 EXHIBIT 10.1 

WISDOMTREE ASSET MANAGEMENT, INC. 

245 Park Avenue, 35th Floor 

New York, New York 10167 

May 1, 2015 
 Mr. Kurt
MacAlpine 
 Dear Kurt: 
 On behalf of
WisdomTree Asset Management, Inc. (“Company”), I am pleased to extend to you a formal offer of employment as an Executive Vice President and Head of Global Distribution of the Company. The terms of your employment will be as follows: 

1. Duties and Start Date. 

(a) In your capacity as Head of Global Distribution, you shall have overall supervision of the sales and distribution functions of the Company
on a global basis and to the extent such functions are performed through direct or indirect foreign subsidiaries of WisdomTree Investments, Inc. (“WTI”) the parent company of the Company, your supervision shall be co-existent with the
principal executive officers of such subsidiaries in a manner to be determined by the Chief Executive Officer of the Company and/or WTI or his/her designee from time to time. You shall also supervise the activities of third party agents retained by
the Company or WTI or any of its subsidiaries to promote the sale of the Company’s funds, and shall have such other executive duties and responsibilities consistent with those positions and assigned to you by the Chief Executive Officer of the
Company and/or WTI or his/her designee from time to time. You shall report to the Chief Executive Officer of the Company and the Head of U.S. Sales of the Company shall report directly to you. You will be a member of the executive team at the
Company, which currently consists of the Chief Executive Officer and President of the Company and four other Executive Vice Presidents. While it is anticipated that you will work closely with the Chief Marketing Officer and Head of Product and
Business Development of the Company, those two positions will not report to you. You shall use your best efforts to promote the interests of the Company and shall devote your full business time, attention and skill to the business and affairs of the
Company. You shall undertake all business travel as required by Company in connection with the performance of your duties hereunder. 
 (b)
Your employment shall commence on a date to be mutually agreed upon, but not later than July 1, 2015. 
 2. Salary. Your Base Salary
will be paid at the rate of $300,000 per annum, commencing as of the date your employment commences (“Start Date”), subject to such increases as may be determined from time to time by the Board of Directors of WTI (or the Compensation
Committee thereof) in its sole discretion. Your salary will be paid in accordance with the Company’s normal payroll policies in effect from time to time. Your salary shall constitute compensation for all hours worked, regardless of the number
of hours worked in any workweek. 

 3. Bonuses. 

(a) You will be entitled to a one-time Sign-On Bonus of $350,000, payable in cash on February 15, 2016, provided, however, that you will not
be eligible to receive this Sign- Bonus if: (i) you are not actively employed by the Company on the date such bonus is to be paid; (ii) you have given notice of termination of your employment to the Company on or before the date such bonus is paid;
or (iii) you have been given notice of termination by the Company on or before the date such bonus is paid. 
 (b) You will be eligible to
participate in discretionary bonus plans that may be established by the Compensation Committee of the Board of Director of WTI in its sole discretion from time to time (the “Discretionary Bonus”). Your Discretionary Bonus, if any, for 2015
will reflect a proration of the amount that would have been considered had you worked for the full year, based on the partial year worked, and such discretionary bonus, if any, shall be paid with a cash/equity mix of 75% cash and 25% equity,
regardless of the normal incentive compensation practice of the Compensation Committee; provided, however, that the cash portion of such bonus after the aforementioned cash/equity split, shall be reduced by the amount of Sign-On Bonus
referred to in Paragraph 2(a) above. Notwithstanding the above, you will not be eligible to receive a Discretionary Bonus if: (i) you are not actively employed by the Company on the date such bonus, if any, is paid; (ii) you have given notice of
termination of your employment to the Company on or before the date such bonus is paid; or (iii) you have been given notice of termination by the Company on or before the date such bonus is paid. 

4. Restricted Stock.
 (a)
You will be entitled to a restricted stock grant of shares of WTI’s common stock (“Restricted Stock”) under WTI’s 2005 Performance Equity Plan with a value equal to $1,000,000 on the effective date of grant, which shall be your
Start Date. The shares of Restricted Stock will vest in three equal annual installments and shall be subject to the terms of the WTI’s standard Restricted Stock Agreement to be entered into on your Start Date; provided however, and
notwithstanding anything to the contrary in the Restricted Stock Agreement, in the event that a termination of your employment by the Company without Cause (as defined below) or a resignation from your employment for Good Reason (as defined below)
occurs prior to January 1, 2017, (i) you shall be entitled to accelerated vesting with respect to the Shares, if any, that would have vested during the twelve-month period immediately following the date of such termination or resignation
(“Post-Employment Period”), which Shares shall vest upon the date of such termination or resignation, (ii) vesting shall otherwise cease as of the last day of your employment. 

(b) The provisions of this Paragraph 4 shall be deemed to amend the Restricted Stock Agreement, it being specifically acknowledged by the
parties hereto that notwithstanding that the Restricted Stock Agreement will be entered into subsequent to the date of this Agreement, the provisions of this Paragraph 4 are intended to supersede the terms of the later dated Restricted Stock
Agreement. 
 5. Protection of Confidential Information and Intellectual Property. 

(a) You agree that your services hereunder are of a special, unique and extraordinary character, and that your position with the Company
places you in a position of confidence and trust. You further acknowledge that in the course of rendering services to the Company, you will obtain knowledge of confidential information and trade secrets of the Company, WTI, direct or indirect
subsidiaries of WTI (whether now existing or subsequently formed, each a “WT Sub” and collectively the “WT Subs”), and 

  
 2 

 
investment companies to which the Company, or any WT Sub has served, or any time hereafter serves, as investment advisor (each a “WT Advised Issuer”) and collectively the “WT
Advised Issuers”). You understand and acknowledge that the Company’s offer of employment is conditioned upon, your specific agreement to be bound the provisions of this Paragraph 5. Accordingly, you agree that during your employment by the
Company and (x) for a one year period thereafter with respect to clause (i) below, and (y) at all times thereafter with respect to clauses (ii) and (iii) below, you will not directly or indirectly: 

(i) solicit, directly or indirectly, any officer, director, employee, or agent of the Company, WTI, any WT Sub or WT Advised Issuer to become
an officer, director, employee, or agent of you or anyone else, 
 (ii) engage or participate in, directly or indirectly, any business
conducted under any name that will be the same as or similar to the name of the Company, WTI, any WT Sub or WT Advised Issuer or any trade name used by any of them, or 

(iii) disparage the reputation of the Company, WTI, any WT Sub or WT Advised Issuer, their respective directors, officers or employees, or the
product and service offerings of the Company, WTI, any WT Sub or WT Advised Issuer or otherwise make, or cause to be made, any statement or communicate any information (whether oral or written) that disparages or reflects negatively on the Company,
WTI, any WT Sub or WT Advised Issuer or their respective directors, officers, employees or agents. 
 (b) You also agree that during your
employment and at all times thereafter, you will not divulge, furnish, or make accessible to anyone (other than on behalf of the Company) any knowledge or information with respect to confidential or secret processes, models, research procedures or
modalities, inventions, discoveries, improvements, formulae, plans, material, devices, ideas, or other know-how, whether intellectual property or not, with respect to any confidential or secret engineering, development, or research work or with
respect to any other confidential or secret aspects of the business of the Company, WTI, any WT Sub or WT Advised Issuer (including, without limitation, the methodology of the market indices developed by the Company, WTI, any WT Sub or WT Advised
Issuer and the terms of business arrangements with service providers to the Company, WTI, any WT Sub or WT Advised Issuer). You further agree that during your employment and at all other times thereafter, you will not make use of, nor permit to be
used, any confidential notes, memoranda, specifications, programs, data, information or other materials of any nature whether oral or written relating to any matter within the scope of the business of the Company, WTI, any WT Sub or WT Advised
Issuer or concerning any of their respective dealings or affairs other than for the benefit of the Company, it being agreed that any of the foregoing will be and remain the sole and exclusive property of the Company, WTI, any WT Sub or WT Advised
Issuer, as the case may be, and that immediately upon the termination of your employment, or at any other time at the Company’s request, you will deliver any or all copies of the foregoing to the Company, as well as any and all other property
of the Company, WTI, any WT Sub or WT Advised Issuer in your possession. 
 (c) During your employment, you will disclose to the Company all
market indices, research procedures, models, ideas, marketing concepts, slogans, advertising campaigns, characters, proposals or plans invented or developed by you which relate directly or indirectly to the business of the Company, WTI, any WT Sub
or WT Advised Issuer or arise out of your employment with the Company or the use of the property or resources of the Company, WTI, any WT Sub or WT Advised Issuer, including, without limitation, any market indices, research procedures, models,
ideas, proposals and plans which may be copyrighted, trademarked, patented or otherwise protected (collectively, “Intellectual Property”). You agree that all such Intellectual Property is the sole property of the Company. You
expressly understand and agree that any and all Intellectual Property constitutes a “work for hire” under the U.S. 

  
 3 

 
Copyright Law. In the event any Intellectual Property is not regarded as a “work for hire,” you hereby assign to the Company the sole and exclusive right to Intellectual
Property. You agree that you will promptly disclose to the Company any and all Intellectual Property, and that, upon request of the Company, you will execute and deliver any and all documents or instruments and take any other action that the
Company deems necessary, to assign to and vest completely in the Company, to perfect trademark, copyright and patent protection with respect to, or to otherwise protect the Company’s trade secrets and proprietary interest in the Intellectual
Property. Upon disclosure of any Intellectual Property to the Company, during your employment and at any time thereafter, you will, at the request and expense of the Company, sign, execute, make and do all such deeds, documents, acts and things as
the Company and its duly authorized agents may reasonably require, among other things: (i) to apply for, obtain and vest in the name of the Company alone (unless the Company otherwise directs) trademarks, copyrights or other analogous
protection in any country throughout the world and when so obtained or vested to renew and restore the same; and (ii) to defend any opposition proceedings in respect of such applications and any opposition proceedings or petitions or applications
for revocation of such trademarks, copyrights, patents or other analogous protection. In the event that you do not, within five days after delivery to you, execute and deliver such documents reasonably necessary to vest in the Company all
right, title and interest in such Intellectual Property, you hereby irrevocably designate and appoint the Company and its duly authorized officers and agents as your agent and attorney-in-fact, to act for and on your behalf and stead to execute and
file any such application or applications and to do all other lawfully permitted acts to further the prosecution and issuance of trademarks, copyright or this analogous protection thereon with the same legal force and effect as if executed by
you. The obligations of this Paragraph 8(c) will continue after the termination of your employment with respect to such Intellectual Property conceived of or developed by you while employed by the Company. The Company agrees to pay any and
all copyright, trademark and patent fees and expenses or this costs incurred by you for any assistance rendered to the Company pursuant to this Paragraph 7(c). 

(d) If you commit a breach, or threaten to commit a breach, of any of the provisions of Paragraphs 5(a), (b) or (c), the Company, WTI, any WT
Sub or WT Advised Issuer, as the case may be, will have the right and remedy: 
 (i) to have the provisions of this Agreement specifically
enforced by any court having equity jurisdiction without being required to post bond or other security and without having to prove the inadequacy of the available remedies at law, including, but not limited to, granting the Company, WTI, any WT Sub
and/or WT Advised Issuer an injunction against you, it being acknowledged and agreed by you that the services being rendered hereunder to the Company are of a special, unique, and extraordinary character and that any such breach or threatened breach
will cause irreparable injury to the Company, WTI, any WT Sub and/or WT Advised Issuer, and that money damages will not provide an adequate remedy to the Company, WTI, any WT Sub and/or WT Advised Issuer; and 

(ii) (x) to require you to account for and pay over to the Company, WTI, any WT Sub and/or WT Advised Issuer all compensation, profits,
monies, accruals, increments, or benefits (collectively “Benefits”) derived or received by you as the result of your breach of any of the provisions of Paragraphs 5(a), (b) or (c) of this Agreement and you hereby agree to account for and
pay over such Benefits to the Company and (y) to cease any severance payments that might otherwise have been payable to you. 
 Each of the rights and
remedies enumerated in this Paragraph 5(d) will be independent of the other, and will be severally enforceable, and such rights and remedies will be in addition to, and not in lieu of, any other rights and remedies available to the Company, WTI, any
WT Sub and/or WT Advised Issuer under law or equity. If any provision of this Agreement is held to be unenforceable, the tribunal making such determination will have the power to modify such provision or provisions, which will then be
applicable in such modified form. 

  
 4 

 6. Representations and Indemnification. You represent and warrant to the Company that you
have the right to be employed by the Company and you are not subject to any contract, commitment, agreement, arrangement or restriction of any kind which might prevent you from performing you duties and obligations hereunder. 

You agree to indemnify the Company against any loss, liability, claim, damage and expense (including but not limited to reasonable
attorney’s fees) to which the Company may be subject in any action brought by a third party arising out of or relating to a breach or alleged breach by you of any of your representations or warranties set forth above. 

7. Severance. If your employment is terminated by the Company prior to January 1, 2017, for any reason other than your death,
“Disability” (as defined below) or for “Cause” (as defined below), or if you resign from your employment prior to January 1, 2017, for “Good Reason” (as defined below) (in any event an “Involuntary
Termination”), then (i) the Company will pay to you, within ten (10) business days following the Involuntary Termination, all accrued but unpaid Base Salary and any discretionary bonus that has been awarded to you by the Board of Directors or
Compensation Committee of WTI but not yet paid, and provided you enter into a fully effective Release Agreement in the form prescribed by the Company, (ii) the Company will pay, in the manner set forth below, as severance to you (or in the case of
your subsequent death, the legal representative of your estate or such other person or persons as you shall have designated by written notice to the Company), an amount equal to sum of: (A) the annual Base Salary set forth in Paragraph 2; and (B)
the cash portion of your targeted discretionary bonus for the year in which Involuntary Termination occurs (collectively the “Severance Amount”). The Severance Amount shall be paid out in substantially equal installments in accordance with
the Company’s payroll practice over twelve months commencing within 60 days after the date of the Involuntary Termination; provided, however, that if the 60-day period begins in one calendar year and ends in a second calendar year, the
Severance Amount shall begin to be paid in the second calendar year, Solely for purposes of Section 409A of the Code, each installment payment is considered a separate payment. In addition, if you elect COBRA insurance coverage, the Company directly
will pay to you on a monthly basis 100% of the amount of such premiums for such insurance for a one-year period following the effective date of your termination. Notwithstanding the foregoing, if you breach any of the provisions contained in
Paragraph 5 of this Agreement, all payments of the Severance Amount and COBRA premiums shall immediately cease. 
 For purposes of this Agreement,
“Disability” shall mean the earlier to occur of either of the following events: 
 (i) you, because of physical or
mental disability or incapacity, are unable to perform your obligations to, or duties for, the Company pursuant to this Agreement on a full-time basis for ninety (90) consecutive days or a period in excess of one hundred fifty (150) days out of any
period of three hundred sixty (360) consecutive days; or 
 (ii) the determination by a physician selected by the
Company, duly licensed in New York with a medical specialty appropriate for such determination (which determination shall be binding and conclusive for the purpose of this Paragraph 7), that you are either physically or mentally, permanently
disabled or incapacitated or otherwise so disabled or incapacitated that he will be unable to perform your obligations to, or duties for, the Company pursuant to this Agreement for ninety (90) consecutive days or a period in excess of one hundred

  
 5 

 
fifty (150) days out of any period of three hundred sixty (360) consecutive days. Your failure to submit to an examination of a physician under this Paragraph 7 shall automatically result in a
determination of disability hereunder. 
 For purposes of this Agreement, “Cause” shall mean any one or more of the following acts or omissions by
you: 
 (i) the willful and continued failure to (A) materially perform your duties and obligations under this Agreement or
(B) to carry out specific legal directions of a senior officer or the Board of Directors of the Company; 
 (ii) the material
breach of any provision of this Agreement (including a breach of the representations and warranties made by you in Paragraph 6 of this Agreement); 

(iii) the material failure to comply with the written policies or rules of the Company; 

(iv) the commission of an act or failure to act that involves willful misconduct, bad faith or gross negligence; 

(v) the commission of any act of fraud, misappropriation, embezzlement or similar willful and malicious conduct against the
Company; or 
 (vi) the conviction of, or plea of “guilty” or “no contest” to, a felony under the laws of
the United States or any state thereof. 
 Notwithstanding the foregoing, cause shall not be deemed to exist for a reason specified in clauses (i)(A) or
(ii) above unless you have been given written notice setting forth in reasonable detail the act, omission or failure of, or breach by, you and a period of at least 10 days after such notice to cure all of such acts, omissions, failures or breaches,
and such shall not have been cured within such 10-day period; provided, further, that the Company shall not be required to give notice and an opportunity to cure for a reason specified in clauses (i)(A) or (ii) if you have committed the same or
substantially similar acts, omissions, failures or breaches and the Company has previously given you notice of and an opportunity to cure the same. 
 For
purposes of this Agreement, “Good Reason” shall mean that you have complied with the “Good Reason Process” (hereinafter defined) following the occurrence of any of the following events: (i) a material diminution in your
responsibilities, authority or duties; (ii) a material diminution in your base salary except for across-the-board salary reductions based on the Company’s financial performance similarly affecting all or substantially all senior management
employees of the Company; (iii) a material change in the geographic location of the principal place to which you provide services to the Company, not including work-related travel or short-term assignments; or (iv) the material breach of this
Agreement by the Company. For purposes of this Agreement, “Good Reason Process” shall mean that (i) you reasonably determine in good faith that a “good reason” condition has occurred; (ii) you notify the Company in writing of the
first occurrence of the good reason condition within 60 days of the first occurrence of such condition; (iii) you cooperate in good faith with the Company’s efforts, for a period not less than 30 days following such notice (the “Cure
Period”), to remedy the condition; (iv) notwithstanding such efforts, the good reason condition continues to exist; and (v) you terminate your employment within 60 days after the end of the Cure Period. If the Company cures the good reason
condition during the Cure Period, good reason shall be deemed not to have occurred. 

  
 6 

 8. Section 409A. 

(a) Anything in this Agreement to the contrary notwithstanding, if at the time of your separation from service within the meaning of Section
409A of the Code, the Company determines that you are a “specified employee” within the meaning of Section 409A(a)(2)(B)(i) of the Code, then to the extent any payment or benefit that you become entitled to under this Agreement on account
of your separation from service would be considered deferred compensation subject to the 20 percent additional tax imposed pursuant to Section 409A(a) of the Code as a result of the application of Section 409A(a)(2)(B)(i) of the Code, such payment
shall not be payable and such benefit shall not be provided until the date that is the earlier of (A) six months and one day after your separation from service, or (B) your death. If any such delayed cash payment is otherwise payable on an
installment basis, the first payment shall include a catch-up payment covering amounts that would otherwise have been paid during the six-month period but for the application of this provision, and the balance of the installments shall be payable in
accordance with their original schedule.  
 (b) All in-kind benefits provided and expenses eligible for reimbursement under this
Agreement shall be provided by the Company or incurred by you during the time periods set forth in this Agreement. All reimbursements shall be paid as soon as administratively practicable, but in no event shall any reimbursement be paid after the
last day of the taxable year following the taxable year in which the expense was incurred. The amount of in-kind benefits provided or reimbursable expenses incurred in one taxable year shall not affect the in-kind benefits to be provided or the
expenses eligible for reimbursement in any other taxable year. Such right to reimbursement or in-kind benefits is not subject to liquidation or exchange for another benefit. 

(c) To the extent that any payment or benefit described in this Agreement constitutes “non-qualified deferred compensation” under
Section 409A of the Code, and to the extent that such payment or benefit is payable upon your termination of employment, then such payments or benefits shall be payable only upon your “separation from service.” The determination of whether
and when a separation from service has occurred shall be made in accordance with the presumptions set forth in Treasury Regulation Section 1.409A 1(h). 

(d) The parties intend that this Agreement will be administered in accordance with Section 409A of the Code. To the extent that any provision
of this Agreement is ambiguous as to its compliance with Section 409A of the Code, the provision shall be read in such a manner so that all payments hereunder comply with Section 409A of the Code. The parties agree that this Agreement may be
amended, as reasonably requested by either party, and as may be necessary to fully comply with Section 409A of the Code and all related rules and regulations in order to preserve the payments and benefits provided hereunder without additional cost
to either party. 
 (e) The Company makes no representation or warranty and shall have no liability to you or any other person if any
provisions of this Agreement are determined to constitute deferred compensation subject to Section 409A of the Code but do not satisfy an exemption from, or the conditions of, such Section. 

Miscellaneous. 
 (a) You
understand and agree that your employment by the Company is on at “at will” basis, subject to the Company’s obligations to pay severance as provided herein. 

(b) You will be entitled to 20 days paid time off per year, to be prorated based on your Start Date. 

  
 7 

 (c) This Agreement, together with Company benefits plans and policies in effect from time to time
collectively, including without limitation the 2005 Performance Equity Plan, the Restricted Stock Agreement with WTI (as amended herein), set forth all of the terms of your employment by the Company, and supersede all prior agreements, whether
written or oral, with respect to your employment by the Company. You acknowledge that you have not relied upon any representations (oral or otherwise) other than those explicitly stated in this Agreement. This Agreement may not be amended, modified
or amended, nor may any term or provision be waived unless such modification, amendment or waiver is in writing and signed by the party against whom enforcement of any such modification, amendment or waiver is sought. The terms of this Agreement and
all rights and obligations of the parties thereto, including its enforcement, shall be interpreted and governed by the laws of the State of New York without regard to principles of conflicts of law. This agreement shall be binding upon and shall
enure to the benefit of the Company’s successors and assigns. A signature received via facsimile or PDF will be deemed an original for all purposes. 

In closing, I want to reiterate how excited we are to have you join us at such a significant time in the development of the Company and look
forward to your important contributions to our success. 
 Please indicate by your signature below your agreement with the terms set forth
above. 
 Sincerely, 
  

			
	WISDOMTREE ASSET MANAGEMENT, INC.
		
	By:	 	 /s/ Jonathan L. Steinberg

		 	Jonathan L. Steinberg, Chief Executive Officer
	
	AGREED AND ACCEPTED:
	
	 /s/ Kurt MacAlpine

	Kurt MacAlpine
	
	Solely to confirm its agreement to the provisions of Paragraph 4:
	
	WISDOMTREE INVESTMENTS, INC.
		
	By:	 	 /s/ Jonathan L. Steinberg

		 	Jonathan L. Steinberg, Chief Executive Officer

  
 8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00258-of-00352.parquet"}]]